These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34997757)

  • 1. Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survival.
    Roos P; Johannsen P; Lindquist SG; Brown JM; Waldemar G; Duno M; Nielsen TT; Budtz-Jørgensen E; Gydesen S; Holm IE; Collinge J; Isaacs AM; ; Nielsen JE
    Acta Neurol Scand; 2022 May; 145(5):529-540. PubMed ID: 34997757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3).
    Rostgaard N; Roos P; Budtz-Jørgensen E; Johannsen P; Waldemar G; Nørremølle A; Lindquist SG; Gydesen S; Brown JM; Collinge J; Isaacs AM; ; Nielsen TT; Nielsen JE
    Neurobiol Aging; 2017 Nov; 59():221.e1-221.e7. PubMed ID: 28888721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review.
    Li C; Wen Y; Zhao M; Wang Y; Li P; Wang L; Wang S
    Mol Genet Genomic Med; 2023 Aug; 11(8):e2222. PubMed ID: 37272767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.
    Toft A; Roos P; Jääskeläinen O; Musaeus CS; Henriksen EE; Johannsen P; Nielsen TT; Herukka SK; Hviid Simonsen A; Nielsen JE
    Dement Geriatr Cogn Disord; 2020; 49(6):533-538. PubMed ID: 33626531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontotemporal dementia caused by CHMP2B mutations.
    Isaacs AM; Johannsen P; Holm I; Nielsen JE;
    Curr Alzheimer Res; 2011 May; 8(3):246-51. PubMed ID: 21222599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory markers of CHMP2B-mediated frontotemporal dementia.
    Roos P; von Essen MR; Nielsen TT; Johannsen P; Stokholm J; Bie AS; Waldemar G; Simonsen AH; Heslegrave A; Zetterberg H; ; Sellebjerg F; Nielsen JE
    J Neuroimmunol; 2018 Nov; 324():136-142. PubMed ID: 30193769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.
    Urwin H; Authier A; Nielsen JE; Metcalf D; Powell C; Froud K; Malcolm DS; Holm I; Johannsen P; Brown J; Fisher EM; van der Zee J; Bruyland M; ; Van Broeckhoven C; Collinge J; Brandner S; Futter C; Isaacs AM
    Hum Mol Genet; 2010 Jun; 19(11):2228-38. PubMed ID: 20223751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
    Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM
    Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation.
    Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM
    Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presymptomatic generalized brain atrophy in frontotemporal dementia caused by CHMP2B mutation.
    Rohrer JD; Ahsan RL; Isaacs AM; Nielsen JE; Ostergaard L; Scahill R; Warren JD; Rossor MN; Fox NC; Johannsen P;
    Dement Geriatr Cogn Disord; 2009; 27(2):182-6. PubMed ID: 19202337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia.
    Rizzu P; van Mil SE; Anar B; Rosso SM; Donker Kaat L; Heutink P; van Swieten JC
    Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):944-6. PubMed ID: 16941655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontotemporal dementia linked to chromosome 3 (FTD-3)--current concepts and the detection of a previously unknown branch of the Danish FTD-3 family.
    Lindquist SG; Braedgaard H; Svenstrup K; Isaacs AM; Nielsen JE;
    Eur J Neurol; 2008 Jul; 15(7):667-70. PubMed ID: 18484988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.
    Skibinski G; Parkinson NJ; Brown JM; Chakrabarti L; Lloyd SL; Hummerich H; Nielsen JE; Hodges JR; Spillantini MG; Thusgaard T; Brandner S; Brun A; Rossor MN; Gade A; Johannsen P; Sørensen SA; Gydesen S; Fisher EM; Collinge J
    Nat Genet; 2005 Aug; 37(8):806-8. PubMed ID: 16041373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene.
    Holm IE; Isaacs AM; Mackenzie IR
    Acta Neuropathol; 2009 Nov; 118(5):719-20. PubMed ID: 19844732
    [No Abstract]   [Full Text] [Related]  

  • 15. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
    Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
    Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
    Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
    Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF neurofilament light concentration is increased in presymptomatic
    Rostgaard N; Roos P; Portelius E; Blennow K; Zetterberg H; Simonsen AH; Nielsen JE
    Neurology; 2018 Jan; 90(2):e157-e163. PubMed ID: 29237796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective activity of ursodeoxycholic acid in CHMP2B
    West RJH; Ugbode C; Fort-Aznar L; Sweeney ST
    Neurobiol Dis; 2020 Oct; 144():105047. PubMed ID: 32801000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration.
    Cannon A; Baker M; Boeve B; Josephs K; Knopman D; Petersen R; Parisi J; Dickison D; Adamson J; Snowden J; Neary D; Mann D; Hutton M; Pickering-Brown SM
    Neurosci Lett; 2006 May; 398(1-2):83-4. PubMed ID: 16431024
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.